These findings support the rationale for additional in-depth studies to elucidate the role of LKB1 signaling, including detailed studies on those targets LKB1 phosphorylates, in breast cancer development in specific molecular subtypes in order to improve clinical outcomes. The gene discussed is STK11; the disease is breast cancer.